Filing Flows › Journey Medical (DERM) › Stock forecast & fair value
Journey Medical (DERM) stock forecast and price target
Journey Medical (DERM) trades at $4.47. 4 analysts' median price target is $13.50 (+202%), from $13.00 to $15.00.
Journey Medical's latest quarter
Journey Medical, Q2 2026: revenue $18.5M (+23% year over year), operating margin 2.5%, net loss $312K, operating cash flow −$1.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for DERM stock?
The median of 4 analysts' 12-month targets is $13.50, +202% from $4.47; the range is $13.00 to $15.00. The average rating is strong buy.
Does Journey Medical usually beat earnings estimates?
It beat the consensus EPS estimate in 75% of the quarters on record.
Is DERM stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.